Navigation Links
Biopure Announces 2007 Third Quarter Financial Results
Date:8/23/2007

CAMBRIDGE, Mass., Aug. 23 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) today announced its financial results for the third fiscal quarter ended July 31, 2007. For the quarter, the company reported a net loss of $6.4 million, or $0.08 per common share, compared with a net loss of $6.6 million, or $0.16 per common share, for the corresponding period in 2006. Class A common shares outstanding on July 31, 2007 and 2006 were 77,960,126 and 41,789,370, respectively.

Revenues

Total revenues for the third quarter of 2007 were $550,000, including $470,000 from sales of the company's veterinary product Oxyglobin(R) and $58,000 from sales of Hemopure(R) in South Africa. Total revenues for the same period in 2006 were $396,000, including $312,000 from Oxyglobin sales and $1,000 from sales of Hemopure(R). The increase in Hemopure sales reflects the company's marketing efforts and increasing use of the product. Oxyglobin revenues increased during the third fiscal quarter of 2007 compared to 2006 due to a higher average selling price for product sold in the U.S.

Cost of revenues was $3.1 million for the third quarter of fiscal 2007, compared to $2.9 million for the same period in 2006. Cost of revenues includes costs of both Oxyglobin and Hemopure. The increase is mainly due to higher salaries expense and plant costs.

Expenses

Research and development expenses were $1.6 million for the third quarter of fiscal 2007 compared to $1.8 million during the same period in 2006. Expenses during the third fiscal quarter of 2006 include costs related to the marketing authorization application the company submitted to the United Kingdom regulatory authority in 2006, for which there are no comparable
'/>"/>

SOURCE Biopure Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 /PRNewswire/ ... the prostate cancer treatment continuum was highlighted prominently ... the American Urological Association (AUA), in San Diego.  ... invasive high intensity focused ultrasound (HIFU) technology, the ... localize disease, and for urologists to consider minimally ...
(Date:5/23/2013)... -- Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company developing innovative ... that it has initiated dosing in a Phase I ... therapy for the treatment of HCV infection. This study will ... to assess both the safety and antiviral efficacy of ... the treatment of chronic HCV infections and is based ...
(Date:5/23/2013)... AVIV, Israel , May 23, 2013 ... BrainTech Israel 2013 , Israel,s ... place on October 14 th -15 th in ... nd most innovative city in the world by the ... "Start-up Nation." BrainTech Israel 2013 will showcase the ...
Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... in Excess of $10 Million; Access Gains Second ... SEOUL, South Korea, Feb. 19 ... and JCOM Ltd , an ... the Republic of Korea, today announced the signing of ...
... Were Performed on AMI Patients in 2008, According to ... Millennium Research Group,s (MRG,s) US Markets for Interventional ... stents will continue to climb steadily through 2013, driven ... coronary intervention (PCI) in Acute Myocardial Infarction (AMI) patients, ...
Cached Medicine Technology:Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea 2Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea 3Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea 4Adoption of PCI in AMI Patients to Drive Drug-Eluting Stent Use 2
(Date:5/23/2013)... May 23, 2013 Former United States ... for Acadian 's annual Paramedic Luncheon. , ... Convention Center, Cheney praised Acadian's medics, saying, "I am ... participate in awarding the Paramedic of the Year Award. ... is a lot of competition within a company like ...
(Date:5/23/2013)... Spring and summer have always been motivation for ... , the city between Memphis and Nashville? In the last ... centers has transformed the growing area into one of the ... city of vibrant, young professionals you are going to see ... White, owner of The Fight Shop, one of the city’s ...
(Date:5/23/2013)... 2013 On April 29th, 2013, UV ... growing numbers of H7N9 cases and deaths. The headline read, ... Cases Will Subside in Northern Hemisphere as Available Daylight Increases ... have been reported. , Quoting Kevin McGuire, president of ... as flowers budding in the spring and leaves changing in ...
(Date:5/23/2013)... May 23, 2013 Parker Waichman LLP, ... of victims injured by defective medical devices and drugs, ... J. McCauley has been appointed Co-Lead Counsel in the ... Products Liability Litigation (Case 7:13-md-02434-CS). The Order, which was ... Counsel are to submit their proposal for the Court’s ...
(Date:5/23/2013)... EnvirOasis, the leader in energy efficient lighting ... pleased to announce its new line of Energy Star ... EnvirOasis has been a market leader in Fluorescent and ... has recently brought to market a full line of ... energy efficient lighting technology which produces a very high ...
Breaking Medicine News(10 mins):Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 3Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 4Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 3Health News:U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation 2Health News:EnvirOasis Lighting Announces Energy Star and Design Lights Consortium LED Products 2
... with a history of severe milk allergy can safely drink ... research led by the Johns Hopkins Children,s Center and published ... of Allergy and Clinical Immunology . Investigators followed up ... earlier Hopkins Children,s-led study published in 2008 in which patients ...
... , NEW YORK, NY, Aug. 18 /PRNewswire-FirstCall/ - (OTCBB: ... that identifies, acquires, and develops novel drug targets that ... Whiteman as its Chief Executive Officer. , Mr. Whiteman, ... London School of Economics . He will provide ...
... , Miami ... Area , , ... today to participating in a conspiracy to defraud the Medicare program of ... Division, U.S. Attorney Terrence Berg of the Eastern District of Michigan and ...
... , HATBORO, Pa., Aug. 18 ... IFLG ), a leading technology provider of enterprise ... that it has successfully achieved Motorola,s Enterprise Mobility Validation for ... Controller (MDC), InfoLogix,s innovative application platform for mobile ...
... , MOUNT PROSPECT, Ill., Aug. 18 The ... KnujOn for spotlighting the exploitation of search engines, advertising programs ... Prescription Drug Sponsored Search Results," released on August 18, 2009, ... Yahoo!,s online advertising program. , , ...
... , PRINCETON, N.J., Aug. 18 Covance (NYSE: ... with Merck to provide a broad array of genomics analysis services ... Gene Expression Laboratory. Effective August 17, 2009, Covance assumed control ... , About Covance , Covance, with ...
Cached Medicine News:Health News:Milk is safe, even encouraged, for some children after treatment for milk allergy 2Health News:GENova names Aaron Whiteman as CEO 2Health News:GENova names Aaron Whiteman as CEO 3Health News:Detroit Clinic Owner and Patient Recruiter Plead Guilty in $15 Million Fraud Scheme 2Health News:Detroit Clinic Owner and Patient Recruiter Plead Guilty in $15 Million Fraud Scheme 3Health News:Detroit Clinic Owner and Patient Recruiter Plead Guilty in $15 Million Fraud Scheme 4Health News:InfoLogix Achieves Motorola Enterprise Mobility Validation 2Health News:InfoLogix Achieves Motorola Enterprise Mobility Validation 3Health News:NABP Applauds LegitScript and KnujOn for Spotlighting Exploitation of Internet Ad Programs by Rogue Internet Drug Outlets 2Health News:Covance and Merck & Co., Inc. Finalize Strategic Agreement 2
... is for arthroscopic and open soft tissue repair ... procedural steps. It may be used with ... in conjunction with,anchors or screws (including suture pre-assembled ... tip permits the placement of a variety of ...
Knot pusher/suture retriever...
... The RC Retractor comes ... allow for superficial or deep ... Retractor permits retraction in three ... inferior. The fiber optic ...
Shoulder rasp...
Medicine Products: